Doctors Lounge - Hematology AnswersBack to Hematology Answers List
If you think you may have a medical emergency, call your doctor or 911 immediately. Doctors Lounge (www.doctorslounge.com) does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site.
DISCLAIMER: The information provided on www.doctorslounge.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Please read our 'Terms and Conditions of Use' carefully before using this site.
Date of last update: 10/12/2017.
Forum Name: Hematology Topics
Question: Lupus anticoagulant
|Deb59 - Mon Jun 20, 2005 10:07 am||
|Dr. Safaa Mahmoud - Wed Jul 26, 2006 2:36 pm||
Lupus anticoagulants (LA) are a heterogeneous group of antibodies that result in different clinical and laboratory effects.
Many Lupus anticoagulant LA are discovered accidentally such as when a prolonged activated partial thromboplastin tim (APTT) is found during a pre-operative evaluation.
The exact etiology of LA is unclear. These antibodies are commonly found in asymptomatic elderly individuals. Among patients with autoimmune disorders, those with SLE have the highest incidence (20-45%). Patients with HIV infection also have a high incidence of LA at some time in their course. A number of drugs are known to induce LA. The majority of patients with drug-induced LA however, have no systemic autoimmune disease or any other underlying disorder and have no clinical manifestations.
Although only a minority of patients with LA present with recurrent episodes of thrombosis, LA are one of the most common acquired predisposing causes of thrombosis.
The typical screening test is a prolongation of the standard APTT that fails to correct when the patient's plasma is mixed with normal plasma. This suggests an inhibitor since normal plasma usually corrects any factor deficiency.
LA may influence the recommendation for the duration or intensity of anticoagulant therapy in patients with thrombotic events.
When LA are found incidentally in asymptomatic patients, no therapy may be necessary. In patients with drug-induced LA, discontinuing the agent will usually cause any abnormal clotting tests to revert to normal in 2-3 weeks.
When thrombotic patients who need anticoagulation with heparin have long APTT's due to a lupus anticoagulant, monitoring the heparin can be accomplished by using the anti-factor Xa activity assay, which is usually used for the monitoring of low molecular weight heparin. Although the PT is less affected by LA than the APTT, the chromogenic factor X assay may be used to determine the accuracy of the INR in patients with LA.
I hope you find you this information useful.
|| Check a doctor's response to similar questions|
Are you a Doctor, Pharmacist, PA or a Nurse?
Join the Doctors Lounge online medical community
Editorial activities: Publish, peer review, edit online articles.
Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.